Technicals Stability Returns

Fundamental Analysis of SMS Pharmaceuticals (SMSPHARMA)

Summary    Balance Sheet    Cash Flow    Income    Qtrly Income    Valuation Ratio    Profitability Ratios    Solvency    Efficiency Ratios    

Guru Numbers
Book Value/Share55.55
EV/EBITDA8.05
Market Cap (Cr)619.65
Enterprise Value (Cr)790.48
Piotroski F-Score7.00
Altman Z Score2.78
Graham No8.98
Price/ Graham 8.15
Peter Lynch Ratio-0.0004
Sloan Ratio0.144
Peter Lynch Fair valueNA
TSR Fair value118.83
Key Financial ratios of SMSPHARMA
Ratio Latest FY Yoy Change TTM MRQ Screener/
About
Price to Earning    12.72 -24.44 % 1135.62    
Price to Book    1.68 -34.37 % 0.665 -0.491    
Price to Sales    1.52 -18.48 % 1.01    
Earning Per Share    7.35 -0.410 % 0.064 0.661    
Return On Equity    13.23 -13.14 % 0.078 -0.444    
Return On Asset    7.24 -5.97 % 0.0415 -0.234    
Net Profit Margin    11.97 7.79 % 0.089 -1.26    
Operating Profit Margin    12.18 -21.78 % 0.803 3.43    
EBITDA Margin    22.99 3.96 % 9.07 7.17    
Debt to Equity Ratio    0.462 -24.24 % 0.558    
Current Ratio    1.92 20.53 % 1.66    
Quick Ratio    0.642 -27.40 % 0.540    
View Historitcal ratios of SMS Pharmaceuticals
Valuation Ratios   Profitability Ratio   Solvency Ratios   Efficiency Ratios
Screen Financial Ratio using Custom Screener
Terrific View
Piotroski F Score - Good Value of 7.0
Undervalued - Price to Intrinsic Value of 0.620
Earning Yield of 9.98 %
Tremendous increasing in Book Value last 3 year
Steady View
Steady increase in Total Assets for last 3 Years
Company financial liquidity has improved
Risky View
Tsr Value Index - Poor Score of 33.33
Tsr Growth Index - Poor Score of 27.79
Tsr Profitability Index - Poor Score of 27.50
Stock Returns < -44.11 % Than Nifty in last one year
Very Low Dividend Yield of 0.390 %
Book value is negative
Negative Net Margin MRQ
Terrific Steady Risky Stock View - Fundamental Snapshot
Share Overview
Promoter Owned64.20 %
Institution Owned0.600 %
Public/Others35.20 %
Outstanding Shares8.47 Cr
Floating Shares2.25 Cr
Floating / Outstanding26.60%
Book Value/Share55.55
Face value1.00
Share Holding
Annual Key Income Statement of SMSPHARMA
Period 31_Mar_2022 31_Mar_2021 Growth
Net Income From Continuing Ops 67.88 60.96 11.35 %
Net Income 62.22 62.53 0.496 %
Operating Income 63.30 87.67 27.80 %
Total Revenue 519.87 563.18 7.69 %
Operating Expense 456.57 475.51 3.98 %
Interest Expense 18.88 11.16 69.18 %
Tax Expense 0.620 30.16 97.94 %
Income Before tax 68.50 91.12 24.82 %
Gross Profit 189.38 181.43 4.38 %
Dividend Paid -2.54 -2.54 0 %
   
Quarterly Key Income Statement of SMSPHARMA
Period 30_Sep_2022 30_Jun_2022 Growth
Net Income From Continuing Ops 0.730 -12.77 105.72 %
Net Income -2.01 -12.77 84.26 %
Operating Income 5.47 -8.74 162.59 %
Total Revenue 159.43 64.39 147.60 %
Operating Expense 145.87 73.13 99.47 %
Interest Expense 5.24 4.85 8.04 %
Tax Expense 0.110 -2.60 104.23 %
Income Before tax 0.840 -12.79 106.57 %
Gross Profit 30.23 15.57 94.16 %
Dividend Paid 0 0 %
   
Key Balance Sheet Fields
Period 31_Mar_2022 31-Mar-21 Growth
Common Stock 8.47 8.47 0 %
Current Liabilities 196.29 194.09 1.13 %
Total Liabilities 389.22 401.68 3.10 %
Current Assets 377.05 309.33 21.89 %
Total Assets 859.50 812.21 5.82 %
Working capital 180.76 115.24 56.86 %
Accounts Payable 72.86 65.44 11.34 %
Inventory 251.10 137.79 82.23 %
Net Receivable 48.52 105.68 54.09 %
   
Key Cash Flow Fields
Period 31_Mar_2022 31_Mar_2021 Growth
Cash EPS 11.82 9.83 20.24 %
Cash From Investment Activity -151.59 -42.56 256.18 %
Cash From Financial Activity 92.02 -2.40 3934.17 %
Cash Operational Activity 90.45 39.71 127.78 %
Net Cash Flow 30.88 -5.25 688.19 %
NetIncome 62.22 62.53 0.496 %
Capital Expenditure 27.25 151.75 82.04 %
Change To Inventory -113.31 -8.59 1219.09 %
   



   About SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.

Address : Plot No. 72, Hyderabad, India, 500034

URL : https://www.smspharma.com

Employee Count : 1031

About TSR TECH Strength / Valuation / Growth

TSR Tech Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is calculate from 5Mins Ticck to One Month Tick

TSR Growth analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access Growth Potential

TSR Value analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access its value

This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.